...
首页> 外文期刊>Journal of Pharmacy and Pharmacology >Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles.
【24h】

Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles.

机译:口服肽递送:硫醇化藻酸盐/聚(丙烯酸)微粒的体外评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The purpose of this study was to develop an oral thiomer-based microparticulate delivery system for insulin by ionic gelation. The microparticulate matrix consisted of either poly(acrylic acid)-cysteine (PAA-Cys) and alginate-cysteine (Alg-Cys) or the corresponding unmodified polymers (PAA, Alg). Two different viscosities of alginates were provided for the study, low and medium. Three different types of microparticles were prepared via ionic gelation with calcium (Alg, AlgPAA and AlgPAA-Cys) and their different properties evaluated in-vitro (particle size and shape, drug loading and release profile, swelling and stability). The mean particle size of all formulations ranged from 400 to 600 microm, revealing the lowest for thiolated microparticles. SEM micrographs showed different morphological profiles for the three different types of microparticles. Encapsulation efficiency of insulin increased within the following rank order: Alg (15%) < AlgPAA (40%) < AlgPAA-Cys (65%). Alginate and AlgPAA microparticles displayed a burst release after 30 min, whereas the thiolated particles achieved a controlled release of insulin over 3 h. The swelling ratio was pH dependent: in simulated intestinal fluid microparticles exhibited a much higher water uptake compared with simulated gastric fluid. Due to the formation of intraparticulate disulfide bonds during the preparation process, thiolated particles revealed a higher stability. It was also observed that the viscosity of the two alginates used had no influence on the properties of the particles. According to these results AlgPAA-Cys microparticles obtained by ionic gelation and stabilized via disulfide bonds might be an alternative tool for the oral administration of therapeutic peptides.
机译:这项研究的目的是通过离子胶凝开发一种基于口服硫聚体的胰岛素微粒递送系统。微粒基质由聚(丙烯酸)-半胱氨酸(PAA-Cys)和藻酸盐-半胱氨酸(Alg-Cys)或相应的未改性聚合物(PAA,Alg)组成。为研究提供了两种不同的藻酸盐粘度,低和中。通过与钙离子凝胶化制备了三种不同类型的微粒(Alg,AlgPAA和AlgPAA-Cys),并在体外评估了它们的不同特性(粒径和形状,载药量和释放曲线,溶胀和稳定性)。所有制剂的平均粒径在400至600微米之间,显示出最小的硫醇化微粒。 SEM显微照片显示了三种不同类型的微粒的不同形态特征。胰岛素的封装效率按以下等级顺序增加:Alg(15%)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号